Literature DB >> 7903856

Immunocytochemical distribution of N-acetylaspartylglutamate in the rat forebrain and glutamatergic pathways.

G Tsai1, B S Slusher, L Sim, J T Coyle.   

Abstract

N-acetylaspartylglutamate (NAAG) is an acidic dipeptide found in high concentration throughout the rat central nervous system. NAAG has been proposed as a neurotransmitter/modulator in some excitatory glutamatergic pathways where it is released by a Ca(2+)-dependent process with neuronal activity. Previous immunocytochemical studies have revealed few neurons exhibiting NAAG-like immunoreactivity (LI) in the forebrain, especially in putative glutamatergic neurons. In this study, we present a detailed map of NAAG-LI in rat forebrain utilizing a modified fixation technique that markedly enhances sensitivity. NAAG-LI is located in most of the putative glutamatergic pathways in the forebrain including pyramidal neurons in motor and sensory cortices and the hippocampal formation. Co-localization of NAAG-LI to cholinergic systems of the forebrain was quite extensive with the exception of the striatal local circuit neurons. A noteworthy feature of NAAG-LI-positive neuronal groups is that they were often configured in hierarchical relationships. For example, the pyramidal neurons of the motor cortex and the motor neurons of the brainstem and and spinal cord expressed NAAG-LI; also, several inter-related components of the limbic system stained for NAAG-LI. Taken together, these findings indicate that NAAG is a neuropeptide localized to subpopulations of neurons throughout forebrain as well as in brainstem and spinal cord.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7903856     DOI: 10.1016/0891-0618(93)90033-z

Source DB:  PubMed          Journal:  J Chem Neuroanat        ISSN: 0891-0618            Impact factor:   3.052


  5 in total

1.  Preclinical evaluation of BAY 1075553, a novel (18)F-labelled inhibitor of prostate-specific membrane antigen for PET imaging of prostate cancer.

Authors:  Ralf Lesche; Georg Kettschau; Alexey V Gromov; Niels Böhnke; Sandra Borkowski; Ursula Mönning; Christa Hegele-Hartung; Olaf Döhr; Ludger M Dinkelborg; Keith Graham
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-08-17       Impact factor: 9.236

2.  GCP II (NAALADase) inhibition suppresses mossy fiber-CA3 synaptic neurotransmission by a presynaptic mechanism.

Authors:  Emilio R Garrido Sanabria; Krystyna M Wozniak; Barbara S Slusher; Asaf Keller
Journal:  J Neurophysiol       Date:  2003-08-13       Impact factor: 2.714

Review 3.  Hypothesis-driven medication discovery for the treatment of psychostimulant addiction.

Authors:  Zheng-Xiong Xi; Eliot L Gardner
Journal:  Curr Drug Abuse Rev       Date:  2008-11

4.  Phenotypic characterization of mice heterozygous for a null mutation of glutamate carboxypeptidase II.

Authors:  Liqun Han; Jonathan D Picker; Laura R Schaevitz; Guochuan Tsai; Jiamin Feng; Zhichun Jiang; Hillary C Chu; Alo C Basu; Joanne Berger-Sweeney; Joseph T Coyle
Journal:  Synapse       Date:  2009-08       Impact factor: 2.562

5.  Dendritic Localization and Exocytosis of NAAG in the Rat Hippocampus.

Authors:  K Nordengen; C Morland; B S Slusher; V Gundersen
Journal:  Cereb Cortex       Date:  2020-03-14       Impact factor: 5.357

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.